Apoptosis in blood diseases: Review - New data;Apoptose et hemopathies: Revue et donnees recentes

Hematology and Cell Therapy

Volumn 38, Issue 3, 1996, Pages 253-264

  Binet, J L ^a   Mentz, F ^a   Merle Beral, H ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Apoptosis; Blood diseases

Indexed keywords

CHLORAMBUCIL; DEXAMETHASONE; FLUDARABINE; METHYLXANTHINE DERIVATIVE; PROTEIN P53; RETINOIC ACID;

ACUTE LEUKEMIA; APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CHRONIC LEUKEMIA; DNA DEGRADATION; DRUG EFFICACY; FOLIC ACID DEFICIENCY; HUMAN; POLYCYTHEMIA; PROTEIN CONFORMATION; REVIEW; THALASSEMIA;

EID: 0029768027     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0253-z     Document Type: Review

References (123)

1. Ahmed A, Bernard M, Bernardo T, et al (1996) Distinct mechanisms for growth factor-independence and inhibition of apoptosis by bcr-abl in Ba/F3 cell line. Hematol Cell Ther 38 : 80-84
2. Alam R, Forsythe P, Stafford S, Fukuda Y (1994) Transforming growth factor beta abrogates the effects of hematoproetins on eosinophils and induces their apoptosis. J Exp Med 179 : 1041-1051
3. Allen PD, Kelsey SM, Newlanda C (1995) Modulation of drug-induced apoptosis in human AML blasts by Atra, vitamin D3 and GM-CSF (abstract). Blood 86 [Suppl 1] : 171a
4. Alvi S, Borok R, Mundle S, et al (1995) Detection of high molecular weight DNA as evidence of apoptosis in myelodysplasia (abstract). Blood 86 [Suppl 1] : 334a
5. American Society of Hematology, thirty-seventh annual meeting (1995) December 1-5, 1995, Seattle, WA, USA
6. Anzai N, Kawabata H, Hirama T, et al (1994) Marked apoptosis of human myelomonocytic leukemia cell line p39 : significance of cellular differentiation. Leukemia 8 : 446-453
7. Apoptosis, an International Journal of programmed cell death (1996) Editor in chief M. Sluyser. The Netherlands Cancer Institute, Amsterdam, Holland
8. Bendall LJ, Daniel A, Kortlepel K, Gottlieb DJ (1994) Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells. Exp Hematol 22 : 1252-1260
9. Bessis M (1964) Studies on cell agony and death : an attempt of classification. Ciba Foundation Symposium "Cellular Injury" de Renck, AVS Knight. Londres, Churchill 287-316
10. Bhalla K, Ibrado AM, Tourkina E, et al (1993) High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood 82 : 3133-3140
11. Bhalla K, Ibrado AM, Tourkina E, et al (1993) Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7 : 563-568
12. Binet JL, Mentz F, Leblond V, Merle-Beral H (1995) Synergistic action of alkylating agents and methylxanthine derivatives in the treatment of chronic lymphocytic leukemia. Leukemia 9 : 2159-2161
13. Bissonnette RP, Echeverri F, Mahboubi A, Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359 : 552-556
14. Bittorf Th, Seiler J, Jaster R, Brock J (1995) The role of protein kinases for erythropoietin-induced suppression of apoptosis in erythroid cell lines (abstract). Blood 86 [Suppl 1] : 659a
15. Bogdanovic A, Jankovic GM, Colovic MD (1996) Apoptosis in bone marrow of myelodysplastic syndrome patients. Blood 87 : 3064-3073
16. Boise LH, Gonzales-Garcia M, Postema CE, D et al (1993) Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 : 597-606
17. Bullock G, Tang C, Tourkina E, et al (1993) Effect of combined treatment with interleukin-3, interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death in human myeloïd leukemia cells. Exp Hematol 21 : 1640-1647
18. Buttke TM, Sandstrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15 : 7-10
19. Calleja E, Menzel T, Konig A, et al(1995) Basic fibroblast growth factor delays DNA topoisomerase inhibitor induced apoptosis in K562 chronic myeloid leukemia cells (abstract). Blood 8 [Suppl 1] : 522a
20. Callera F, Garcia AB, Falcao RP (1995) Increased Fas antigen expression on lymphocytes from severe aplastic anemia (abstract). Blood 86 [Suppl 1] : 478a
21. Cantwell MJ, Kipps TJ (1995) CD 95 expression and apoptosis of chronic lymphocytic leukemia B cells (abstract). Blood 86 [Suppl 1] : 346a
22. Chaouchi N, Wallar C, Tailli J, et al (1994) Interferon-alpha mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells. Role of bcl-2 and c-myc. Clin immunol Immunopathol 73 : 1-8
23. Chaouchi N, Wallon C, Goujard C et al (1996) Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 87 : 1022-1029
24. Chauhan D, Kharbanda SM, Ogata A, et al (1995) Fas induces apoptosis and stress activated protein (SAP) kinase activation in RPMI-8226 multiple myeloma (MM) cells which is inhibited by interleukin-6 (IL-6) (abstract). Blood 86 [Suppl 1] : 277a
25. Clark E, Mundle S, Broady-Robinson L, et al (1995) A direct in vivo evidence of spontaneous signal antonymy found characteristically in myelodysplastic syndromes (abstract). Blood 86 [Suppl 1] : 271a
26. Clarke AR, Purdie CA, Harrisond J, Morris RG, Bird CC, Hooper ML et al (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362 : 849-852
27. Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JFR (1989) Spontaneous programmed cell death (apoptosis) of B-chronic lymphocytic leukemia cells. Br J Haematol 71 : 343-350
28. Culotta E, Koshland Jr DE (1993) p53 sweeps through cancer research. Science 262 : 1958-1961
29. Dazynkiewicz Z, Li X (1995) Measurements of cell death by flow cytometry techniques in apoptosis : A user guide. TG Cotter, SJ Martin (eds) Portland, Londres, pp 77-92
30. Di Pietro R, Falcieri E, Centurione L, et al (1994) Ultrastructural patterns of cell damage and death following gamma radiation exposure of murine erythroleukemia cells. Scanning Microsc 8 : 667-673
31. Donehower LA, Harvey M, Slagle BL, et al (1992) p53 deficient mice are developmentally normal but susceptible to spontaneous tumours. Nature 356 : 215-221
32. Drolshagen H, Kleine HD, Freund M (1995) Expression of Apo-1-receptor and apoptosis rates can be increased by interleukin-2 in chronic lymphocytic leukemia (abstract). Blood 86 [Suppl 1] : 347a
33. Efferth T, Fabry U, Glatte P, Osieka R (1995) Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patient J Mol Med 73 : 47-49
34. Efferth T, Fabry U, Glatte P, Osieka R (1995) Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol 12 : 648-656
35. El Tounsi I, Consoli U, Younes A, et al (1995) Upregulation of FAS expression in B-chronic lymphocytic leukemia (CLL) cells by IL-2 and IL-7 is associated with enhancement of FAS ligand (FasL) (abstract). Blood 86 [Suppl 1] : 346a
36. L may confer résistance to FAS/FAS ligand mediated apoptosis in chronic lymphocytic leukemia (CLL) cells (abstract). Blood 86 [Suppl 1] : 346a
37. Evan GI, Wyllie AN, Gilbert CS, et al (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69 : 119
38. Falcieri E, Gobbi P, Cataldi A, et al (1994) Nuclear pores in the apoptotic cell. Histochem J 26 : 754-763
39. Fluckiger AC, Durand I, Banchereau J (1994) Interleukin-10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179 : 91-99
40. Fukuchi K, Tomoyasu S, Tsuruoka N, Gomi K (1994) Iron deprivation-induced apoptosis in HL-60 cells. FEBS Lett 350 : 139-142
41. Ginis I and Faller DV (1995) Integrin-mediated adhesion to activated endothelium protects human neutrophils from apoptosis (abstract). Blood 86 [Suppl 1] : 501a
42. Ginis I, Zaner K, Wang JS, Pavlotsky N, Tauber AI (1992) Comparison of actin changes and calcium metabolism in plastic- and fibronectin-adherent human neutrophils. J Immunol 149 : 1388-1394
43. Goto N, Tojo A, Shibuya M (1995) A novel she to myc pathway through which IL-3 signals to inhibit apoptosis of hematopoietic cells (abstract). Blood 86 [Suppl 1] : 153a
44. Guglielmo P, Stagno F, Cacciola E, et al (1995) All trans-retinoic acid (ATRA) induced apoptosis in peripheral freshly isolated chronic myeloid leukemia cells (abstract). Blood 86 [Suppl 1] : 523a
45. Guo KY, Chen J, Chen GQ, Wang W (1995) Anti-Fas/APO-1 MoAb induced apoptosis of AML, HL60 cells (abstract). Blood 86 [Suppl 1] : 761a
46. Hata H, Matsuzaki H, Takeya M, et al (1995) Expression of Fas/apo1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. Blood 86 : 1939-1945
47. Henderson S, Rowe M, Gregory C et al (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65 : 1107-1115
48. Huang P, Robertson LE, Wright S, Plunkett W (1996) High molecular weight DNA fragmentation: a critical event in nucleoside analoginduced apoptosis in leukemia cells. Clinical Cancer Res (In press)
49. Iseki R, Mukai M, Iwata M (1991) Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation and glucocorticoïd-induced death. J Immunol 147 : 4286-4292
50. Jewell AP, Lydyard MM, Worman CP, Giles FJ, Goldstone AH (1995) Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation. Leuk lymph 18 : 159-162
51. Juckett M, Shadley J, Zheng Y (1995) Iron depravation reduces clonogenic survival, induces apoptosis and enhances radiation toxicity in endothelial cells (abstract). Blood 86 [Suppl 1] : 976a
52. Jurlander J, Lau CF, Tan J, et al (1995) Interleukin-10 (IL-10) ia a survival factor for B cell chronic lymphocytic leukemia (B-CLL) (abstract). Blood 86 [Suppl 1] : 346a
53. Kanter L, Hellstrom-Lindberg E, Kock Y, et al (1995) Erythropoietic effectiveness and apoptosis in patients with myelodysplastic syndromes (MDS) treated with G-CSF and EPO (abstract). Blood 86 [Suppl 1] : 338a
54. Keith FJ, Tiong HY, Bradbury DA, Russell NH (1995) The effect of temperature on apoptosis and p53 conformation in CD34+ CML cells (abstract). Blood 86 [Suppl 1] : 522a
55. Kerr JFR, Winterford CM, Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73 : 2013-2026
56. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 : 239-257
57. Kiehntopf M, Duyster J, Karawajew L, et al (1995) Cell-permeable peptides complementary to functional domains of Bcl-2 restore glucocorticoide-sensitivity in previously resistant multiple myeloma cells (abstract). Blood 86 [Suppl 1] : 60a
58. Kitada S, Andersen J, Hines J, et al (1995) Expression of bcl-2 family genes and in vitro sensitivity to fludarabine and 2-chlorodeoxy-adenosine in B-CLL : an ecog study (abstract). Blood 86 [Suppl 1] : 607a
59. Komada Y, Zhou YW, Zhang XL, et al (1995) Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 86 : 3848-3860
60. Koury MJ, Horne DW, Blount BC, Ames BN (1995) Erythroblasts undergoing apoptosis due to folate deficiency misincorporate uracil into DNA and accumulate the tumor suppressor protein p53 (abstract). Blood 86 [Suppl 1] : 584a
61. Kravtsov V, Lishner M, Fabian I (1995) A novel approach to study apoptosis in freshly isolated myeloblasts and chronic lymphocytic leukemia cells (abstract). Blood 86 [Suppl 1] : 837a
62. Kuwakado K, Kubota M, Hirota H, et al (1993) Aphidicolin potentiates apoptosis induced by arabinosyl nucleosides in human myeloid leukemia cell lines. Biochem Pharmacol 46 : 1909-1916
63. Lagarkova MA, Iarovaia OV, Razin SV (1995) Large-Scale fragmentation of mammalian DNA in the course of apoptosis proceeds via excision of chromosomal DNA loops ant their oligomers. J Biol Chem 270 : 20239-20241
64. Lane DP (1992) p53, guardian of the genome. Nature 358 : 15-16
65. Lepelley P, Campergue L, Preudhomme C, et al (1996) Apoptosis in myelodysplastic syndromes. Hematol Cell Ther 38 : 78-83
66. Link DC, Rodel JE (1995) Suppression of apoptosis during cytokine deprivation of 32D cells is not sufficient to induce granulocytic differentiation (abstract). Blood 86 [Suppl 1] : 672a
67. Lisovsky M, Estrov Z, Consoli U, Munker R, Andreeff M (1995) Flt3 LIGAND stimulates proliferation and inhibits apoptosis of acute myeloid leukemia blasts (abstract). Blood 86 [Suppl 1] : 22a
68. Lopez-Rivas A, Martinez C, Lamotte M (1995) The third European euroconference on apoptosis, Commission of European communities. October. Spain, Cuenca
69. Mainou-Fowler T, Craig VA, Copplestone JA, et al (1994) Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4. Blood 84 : 2297-2304
70. Majno A, Joris I (1995) Apoptosis, oncosis, and necrosis. An over-view of cell death. Am J pathol 146-151
71. Massaya M, Borrione P, Attisano C, et al (1995) Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood 85 : 3679-3687
72. McConkey DJ, Orrenius S, Jondal M (1990) Cellular signalling in programmed cell death (apoptosis). Immunol Today 11 : 120-131
73. McKenna SL, Hoy T, Padua RA, et al (1995) Detection of drug induced apoptosis in chronic lymphocytic leukaemia using the nick translation assay : correlation with clinical response (abstract). Blood 86 [Suppl 1] : 839a
74. Mentz F, Djavad Mossalayi M, Ouaaz F, et al (1996) Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood (in press)
75. Mentz F, Merle-Beral H, Ouaaz F, Binet JL (1995) Theophylline, a new inducer of apoptosis in B-CLL : role of cyclic nucleotides. Br J Haematol 90 : 957-959
76. Menzel T, Rahman Z, Calleja E, et al (1996) Elevated intracellular level of basis Ebroblast growth factor correlates with stage of chronic Iymphocytic leukemia and is associated with resistance to fludarabine. Blood 87 : 1056-1063
77. Merle-Beral H, Mentz F, Mossalayi MD, et al (1995) Chlorambuciland-theophylline-induced apoptosis in B chronic lymphocytic leukemia (abstract). Blood 86 [Suppl 1] : 347a
78. Miyashita T, Krajewski S, Krajewska M, et al (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9 : 1799-1804
79. Moscinski LC, Hill B, Blair P (1995) 2-CdA induces apoptosis in acute myelogenous leukemia blast cells during GO-G1 phase of the cell cycle (abstract). Blood 86 [Suppl 1] : 772a
80. Mundle S, Alvi S, Ddong LM, et al (1995) Interleukin 1 beta converting enzyme-like protease may be involved in the intramedullary apoptotic death in the marrows of patients with myelodysplasia (abstract). Blood 86 [Suppl 1] : 334a
81. Mundle S, Iftikhar A, Shetty V, et al (1994) Novel in situ double labelling for simultaneous detection of proliferation and apoptosis. J Histochem Cytochem 42 : 1533-1537
82. Munker R, Zhao S, Thomas E, Andreeff M (1995) Induction of CD95 (Fas/Apo-1) HLA-DR and CD54 on blasts of acute myelogenous leukemias by TNF-alpha and IFN-gamma and resistance to Fas-mediated apoptosis (abstract). Blood 86 [Suppl 1] : 772a
83. Murakami M, Tsubata T, Okamoto M, et al (1992) Antigen-induced apoptotic death of Ly-1 B cells responsible for auto-immune disease in transgenic mice. Nature 357 : 77-80
84. Murohashi I, Yoshida K, Handa A, et al (1995) Mechanisms of apoptosis of blast cells from patients with acute myeloblastic leukemia (abstract). Blood 86 [Suppl 1] : 700a
85. Nagata S, Goldstein P (1995) The Fas death factor. Science 267 : 1449-1456
86. Nishihara T, Okahashi N, Ueda N (1993) Activin A induces apoptic cell death. Biochem Biophys Res Commun 197 : 985-991
87. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 : 609-619
88. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand V (1993) Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 85 : 439-444
89. Panayiotidis P, Ganeshaguru K, Jabar SAB, Hoffbrand AV (1993) Alpha-interferon protects B chronic lymphocytic Leukaemia cells from apoptotic cell death in vitro. Br J Haematol 86 : 169-173
90. Panayiotidis P, Jones D, GaneshaGuru K, et al (1996) Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukemia cells in vitro. Br J Haematol 92 : 97-103
91. Panayiotidis P, Jones D, Ganeshaguru K, et al (1996) Human bone marrow stromal cells prevent apoptotis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 92 : 97-103
92. Panayiotidis P, Reime JR, Ganeshaguru K, et al (1995) Expression and regulation of apoptosis related genes in B-Chronic lymphocytic leukaemia (CLL) (abstract). Blood 86 [Suppl 1] : 607a
93. Perdahl EB, Najoretek BL, Wallace WC, Lipton JM (1994) Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 83 : 645-650
94. Philipott NJ, et al (1995) Increased apoptosis in aplastic anemia bone marrow progenitor cells : possible pathophysiologic significance. Exp Hematol 23 : 1642-1648
95. Quadros EV, McLoughlin P, Rothenberg S, et al (1995) Epitope specific monoclonal antibodies (mAbs) to human transcobalamin II (TCII) can induce apoptosis by inhibiting the cellular uptake of cobalamin (Cb1) (abstract). Blood 86 [Suppl 1] : 125a
96. Rameshwar P, Gascon P (1995) Endogenous endopeptidase and protection of progenitor cells from apoptosis contribute to the hematopoietic regulatory mechanisms exerted by substance P (SP) (abstract). Blood 86 [Suppl 1] : 678a
97. Raza A, Gezer S, Gregory S, et al (1995) Extensive intramedullary apoptosis may be the basis for ineffective hematopoiesis in myelodysplastic syndromes (abstract). Blood 86 [Suppl 1] : 334a
98. Raza A, Gezer S, Mundle S, et al (1995) Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 48 : 268-276
99. Rey JP, Scott R, Muller H (1994) Apoptosis is not involved in the hypersensitivity of Fanconi anemia cells to mitomycin C. Cancer Genet Cytogenet 75 : 67-71
100. Ritchie A, Vadhan-Raj S, Broxmeyer HE (1995) Thrombopoietin suppresses growth factor withdrawal-induced apoptosis and behaves as a survival factor for the human growth factor-dependent cell line M07e (abstract). Blood 86 [Suppl 1] : 21a
101. Robertson KA, Hill D, Ewing C, et al (1995) The Myeloid Zinc Finger gene (MZF-1) inhibits retinoic acid induced apoptosis and CD18 expression in HL-60 cells (abstract). Blood 86 [Suppl 1] : 14a
102. Robertson LE, Chubb S, Meyn RE, et al (1993) Induction of apoptotic cell death in CLL by 2 CDA and BBd arabinofuranosyl-2 fluoroadenine. Blood 81 : 143-148
103. Roger R, Issaad C, Pallardy M, et al (1996) Bcr-abl does not prevent apoptotic death induced by human natural killer or lymphokine-activaled killer cells. Blood 87 : 1113-1122
104. Sachs L, Lotem J (1993) Control of programmed cell death in normal and leukemic cells : new implications for therapy. Blood 82 : 15-21
105. Santini V, Gozzini A, Scappini B, et al (1995) Butyrate stable monosaccharide derivatives induce maturation and apoptosis in primarv human acute myeloid leukemia cells and in cell lines in synergy with G-CSF (abstract). Blood 86 [Suppl 1] : 680a
106. Schulze-Osthoff K, Walczak H, Dröge W, Krammer PH (1994) Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127 : 15-20
107. Simon HU, Blaser K (1995) Inhibition of programmed cell death: a key pathogenic event for eosinophilia ? Immunol Today 16 : 53-55
108. Smith CA, Williams GT, Kingston R, et al (1989) Antibodies to CD3/T cells receptor complex induced by apoptosis in immature T cells in thymic cultures. Nature 337 : 181-184
109. Snell V, Consoli U, Hude K, et al (1995) Rapamycin enhances Ara-C and idarubicin induced apoptosis in AML in vitro (abstract). Blood 86 [Suppl 1]: 513a
110. Taetle R, Dos Santos B, Akamatsu KI, et al (1995) Effects of all-trans retinoic acid and anti-growth factor receptor antibodies on growth and programmed cell death of human myeloma cells (abstract). Blood 86 [Suppl 1] : 189a
111. Taga K, Chretien J, Cheney B, et al (1994) Interleukin-10 inhibits apoptotic cell death in infections mononucleosis cells. J Clin Invest 94 : 251-260
112. Tian E, Lee JH, Tricot G, et al (1995) Bcl-2 and not bax protein is the rate-limiting step in dexamethasone (Dex)-induced apoptosis in myeloma cells (abstract). Blood 86 [Suppl 1] : 61a
113. Turner AM, Lin NL, Lyman SD, Broudy VC (1995) Characterization of flt3 receptor expression on normal and malignant human hematopoietic cells (abstract). Blood 86 [Suppl 1] : 22a
114. Vaux DL (1993) Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA, 90, 786-792
115. Weekes CD, Lang M, Pirrucello S, et al (1995) Stroma maintains the survival of B lymphoma cells by inhibiting apoptosis (abstract). Blood 86 [Suppl 1] : 826a
116. Westendorf JJ, Lammert JM, Jelinek DF (1995) Expression and function of Fas(APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood 85 : 3566-3576
117. Xu F, Tu Y, Liu J, et al (1995) Interleukin-6 protection against multiple myeloma plasma cells : Role of cell cycle alterations, Bcl-famiiy of proteins and protein tyrosine kinases (abstract). Blood 86 [Suppl 1] : 61a
118. Yao A, Macleod SL, Barlogie B, Hardin JW (1995) Multiple myeloma cells contain functional estrogen receptors (ER) mediating suppression of IL-6 but not of cell growth (abstract). Blood 86 [Suppl 1] : 64a
119. Yonish-Rouach E, Resnistky D, Lotem J, et al (1991) Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352 : 345-347
120. Yuan J, Angeluca E, Lucarelli G, et al (1993) Accelerated programmed cell death in erythroid precursors of patients with severe beta-thalassemia. Blood 82 : 374-377
121. Yuan J, Rubin E, Paszty C, Schrier SL (1995) Programmed erythroid cell death in the spleens of beta (b) thalassemic mice (abstract). Blood 86 [Suppl 1]: 8a
122. Zhang X, Siegel D, Pearse B, Michaeli J (1995) Distinct apoptotic pathways in human myeloma cells in response to dexamethasone (DEX) and the differentiation inducer hexamethylene bisacetamide (HMBA) (abstract). Blood 86 [Suppl 1] : 62a
123. Zhou D, Wu Y, Zhang Z (1995) Apoptosis in the pathogenesis of polycythemia vera (abstract). Blood 86 [Suppl 1] : 50a